Shengkai Zuo

1.0k total citations
30 papers, 613 citations indexed

About

Shengkai Zuo is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Shengkai Zuo has authored 30 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Cardiology and Cardiovascular Medicine and 8 papers in Oncology. Recurrent topics in Shengkai Zuo's work include Peptidase Inhibition and Analysis (5 papers), Cardiac Fibrosis and Remodeling (5 papers) and Signaling Pathways in Disease (3 papers). Shengkai Zuo is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Cardiac Fibrosis and Remodeling (5 papers) and Signaling Pathways in Disease (3 papers). Shengkai Zuo collaborates with scholars based in China, United States and Japan. Shengkai Zuo's co-authors include Ying Yu, Yujun Shen, Deping Kong, Jiao Liu, Bei Wang, Michael Lazarus, Guizhu Liu, Yuxuan Jin, Yuanyang Wang and Qian Liu and has published in prestigious journals such as Circulation, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Shengkai Zuo

26 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengkai Zuo China 16 279 124 116 83 75 30 613
Trevor P. Fidler United States 16 369 1.3× 92 0.7× 175 1.5× 87 1.0× 95 1.3× 18 877
Liang Xie United States 13 248 0.9× 116 0.9× 99 0.9× 45 0.5× 106 1.4× 20 568
Anna Kobsar Germany 16 243 0.9× 279 2.3× 159 1.4× 61 0.7× 53 0.7× 44 967
Mingqi Tan China 13 436 1.6× 61 0.5× 98 0.8× 128 1.5× 76 1.0× 19 720
Hanna E. Agardh Sweden 13 294 1.1× 170 1.4× 310 2.7× 103 1.2× 108 1.4× 15 866
Zeqi Zheng China 17 381 1.4× 191 1.5× 78 0.7× 102 1.2× 158 2.1× 48 786
Giovanna Baccante Italy 15 172 0.6× 116 0.9× 119 1.0× 50 0.6× 60 0.8× 19 546
James Surapisitchat United States 11 581 2.1× 135 1.1× 204 1.8× 69 0.8× 73 1.0× 13 946
Patrick S. Lin United States 13 442 1.6× 256 2.1× 110 0.9× 59 0.7× 64 0.9× 23 1.0k
Boda Zhou China 13 324 1.2× 88 0.7× 52 0.4× 32 0.4× 89 1.2× 44 554

Countries citing papers authored by Shengkai Zuo

Since Specialization
Citations

This map shows the geographic impact of Shengkai Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengkai Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengkai Zuo more than expected).

Fields of papers citing papers by Shengkai Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengkai Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengkai Zuo. The network helps show where Shengkai Zuo may publish in the future.

Co-authorship network of co-authors of Shengkai Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Shengkai Zuo. A scholar is included among the top collaborators of Shengkai Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengkai Zuo. Shengkai Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Ting, Rui Xiao, Jingyuan Zhao, et al.. (2025). (+)-JQ-1 alleviates cardiac injury in myocardial infarction by inhibiting ferroptosis through the NAMPT/SIRT1 pathway. Cell Death and Disease. 16(1). 548–548. 2 indexed citations
3.
4.
Liu, Jiao, Yuxuan Jin, Shengkai Zuo, et al.. (2025). Dot1L Promotes Stress-Induced Cardiac Hypertrophy in Mice via Tbx6. Circulation Research. 137(4). 496–512.
5.
Yan, Shuai, Yuanyang Wang, Bei Wang, Shengkai Zuo, & Ying Yu. (2024). Thromboxane A2 Modulates de novo Synthesis of Adrenal Corticosterone in Mice via p38/14‐3‐3γ/StAR Signaling. Advanced Science. 11(18). e2307926–e2307926. 1 indexed citations
6.
Mu, Jiuke, Lixue Yang, Nan Sheng, et al.. (2024). Advancing medical devices with soft actuators. 3(1). 100112–100112. 1 indexed citations
7.
Hu, Jiayi, et al.. (2024). Aerobic training attenuates cardiac remodeling in mice post‐myocardial infarction by inhibiting the p300/ CBP ‐associated factor. The FASEB Journal. 38(13). e23780–e23780. 2 indexed citations
8.
Wang, Bei, Yuxuan Jin, Jiao Liu, et al.. (2023). EP1 activation inhibits doxorubicin-cardiomyocyte ferroptosis via Nrf2. Redox Biology. 65. 102825–102825. 67 indexed citations
9.
Feng, Xiangling, Qian Ouyang, Qiaoli Chen, et al.. (2022). PGE 2 ‐EP3 axis promotes brown adipose tissue formation through stabilization of WTAP RNA methyltransferase. The EMBO Journal. 41(16). e110439–e110439. 19 indexed citations
10.
Wang, Bei, Shengkai Zuo, Mei Du, et al.. (2022). Protective effects of CRTH2 suppression in dry age-related macular degeneration. Biochemical and Biophysical Research Communications. 624. 8–15. 3 indexed citations
11.
Liu, Jiao, Yuxuan Jin, Bei Wang, et al.. (2021). Dopamine D1 receptor alleviates doxorubicin-induced cardiac injury by inhibiting NLRP3 inflammasome. Biochemical and Biophysical Research Communications. 561. 7–13. 17 indexed citations
12.
Zuo, Shengkai, Bei Wang, Jiao Liu, et al.. (2021). ER‐anchored CRTH2 antagonizes collagen biosynthesis and organ fibrosis via binding LARP6. The EMBO Journal. 40(16). e107403–e107403. 24 indexed citations
13.
Kong, Deping, Qiangyou Wan, Juanjuan Li, et al.. (2020). DP1 Activation Reverses Age-Related Hypertension Via NEDD4L-Mediated T-Bet Degradation in T Cells. Circulation. 141(8). 655–666. 30 indexed citations
14.
Cui, Hui, Shengkai Zuo, Zipeng Liu, et al.. (2020). The support of genetic evidence for cardiovascular risk induced by antineoplastic drugs. Science Advances. 6(42). 10 indexed citations
15.
Zuo, Shengkai, Deping Kong, Chenyao Wang, et al.. (2018). CRTH2 promotes endoplasmic reticulum stress‐induced cardiomyocyte apoptosis through m‐calpain. EMBO Molecular Medicine. 10(3). 69 indexed citations
16.
Liu, Guizhu, Qian Liu, Yujun Shen, et al.. (2017). Early treatment with Resolvin E1 facilitates myocardial recovery from ischaemia in mice. British Journal of Pharmacology. 175(8). 1205–1216. 42 indexed citations
17.
Kong, Deping, Juanjuan Li, Yujun Shen, et al.. (2017). Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D2 Receptor Subtype 1. Journal of Pharmacology and Experimental Therapeutics. 360(3). 435–444. 18 indexed citations
18.
Tang, Juan, Yujun Shen, Guilin Chen, et al.. (2017). Activation of E-prostanoid 3 receptor in macrophages facilitates cardiac healing after myocardial infarction. Nature Communications. 8(1). 14656–14656. 39 indexed citations
19.
Shen, Yujun, Shengkai Zuo, Yuanyang Wang, et al.. (2016). Thromboxane Governs the Differentiation of Adipose-Derived Stromal Cells Toward Endothelial Cells In Vitro and In Vivo. Circulation Research. 118(8). 1194–1207. 13 indexed citations
20.
Yang, Quan, Limei Zhong, Maohua Shi, et al.. (2014). Cross Talk between Histone Deacetylase 4 and STAT6 in the Transcriptional Regulation of Arginase 1 during Mouse Dendritic Cell Differentiation. Molecular and Cellular Biology. 35(1). 63–75. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Trevor P. Fidler Breakdown of academic impact, for papers by Liang Xie Breakdown of academic impact, for papers by Anna Kobsar Breakdown of academic impact, for papers by Mingqi Tan Breakdown of academic impact, for papers by Hanna E. Agardh Breakdown of academic impact, for papers by Zeqi Zheng Breakdown of academic impact, for papers by Giovanna Baccante Breakdown of academic impact, for papers by James Surapisitchat Breakdown of academic impact, for papers by Patrick S. Lin Breakdown of academic impact, for papers by Boda Zhou
Rankless by CCL
2026